Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00108810 · ClinicalTrials.gov registry record · Phase 2
Transdermal Ketoprofen to Treat Mild to Moderate Osteoarthritis (OA) Pain of the Knee
A Phase 2 study of Pain and Osteoarthritis, Knee, sponsored by ZARS Pharma.
- Completed
- Registry status
- Phase 2
- Development phase
- 118
- Enrollment target
- 5
- Study locations
NCT00108810 is a Phase 2 study of Pain and Osteoarthritis, Knee that has completed, run by ZARS Pharma. The registered enrollment target is 118 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (61% lower). The trial reports 5 study locations across 4 states.
The verdict
NCT00108810, a Phase 2 study of Pain and Osteoarthritis, Knee, has completed, sponsored by ZARS Pharma.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 118 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of the study is to evaluate the safety and effectiveness of the investigational ketoprofen patch with a controlled heating patch, compared to placebo (inactive substance) for the treatment of pain caused by osteoarthritis.
Conditions Studied
Interventions
- DRUG Placebo transdermal patch
- DRUG Transdermal Ketoprofen Patch with CHADD
Study Locations (5)
Florida
- Radiant Research - Daytona Beach
- University Clinical Research - Pembroke Pines
California
- SouthBay Pharma Research - Buena Park
District of Columbia
- The Center for Rheumatology and Bone Research - Washington D.C.
New York
- Hospital for Special Surgery - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2005-04 |
| Est. Completion | 2005-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00108810
The ClinicalTrials.gov registry entry for NCT00108810 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 118 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (61% lower). The listed sponsor is ZARS Pharma, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Placebo transdermal patch is the first listed.
NCT00108810 reports 5 study locations spanning 4 distinct geographic areas - top geographies include Florida, California, District of Columbia.
Frequently Asked Questions
What is clinical trial NCT00108810 about?
NCT00108810 is a clinical study titled "Transdermal Ketoprofen to Treat Mild to Moderate Osteoarthritis (OA) Pain of the Knee". The purpose of the study is to evaluate the safety and effectiveness of the investigational ketoprofen patch with a controlled heating patch, compared to placebo (inactive substance) for the treatment of pain caused by osteoarthritis.
What is the current status of trial NCT00108810?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 118 participants. The study started on 2005-04. Estimated completion is 2005-10.
What conditions does trial NCT00108810 study?
This clinical trial studies the following conditions: Pain, Osteoarthritis, Knee.
What interventions are being tested in trial NCT00108810?
The interventions under investigation include: Placebo transdermal patch (DRUG), Transdermal Ketoprofen Patch with CHADD (DRUG).
Who is sponsoring clinical trial NCT00108810?
This trial is sponsored by ZARS Pharma, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00108810 being conducted?
This trial has 5 study locations across California, District of Columbia, Florida, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism
RECRUITING · Phase 2
-
Cannabidiol and Older Adult Cannabis Users
RECRUITING · Phase 2
-
Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype
RECRUITING · Phase 2
-
Neural Correlates of Hypoalgesia Driven by Observation
RECRUITING · Phase 2
-
Cannabis for Palliative Care in Cancer
RECRUITING · Phase 2
-
Pain After Buffered Vs Non Buffered Articaine
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.